Foreign Competition Drives India Pharma Move To Greater R&D Investment
This article was originally published in PharmAsia News
Executive Summary
Foreign competition has led Indian drug makers to invest more in research and development, to the extent the domestic industry has transformed itself into a major global hub worthy of eighth place among the world's countries in terms of R&D spending.